Meningococcal meningitis, unspecified
ICD-10 A39.4 is a billable code used to indicate a diagnosis of meningococcal meningitis, unspecified.
Meningococcal meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, caused by the bacterium Neisseria meningitidis. This condition can lead to severe complications, including neurological damage, septicemia, and death if not treated promptly. The unspecified designation indicates that the specific serogroup of Neisseria meningitidis has not been identified, which can complicate treatment decisions and epidemiological tracking. Symptoms typically include fever, headache, stiff neck, nausea, vomiting, and altered mental status. Diagnosis is confirmed through lumbar puncture and cerebrospinal fluid analysis, which may show elevated white blood cell counts, low glucose levels, and the presence of bacteria. Treatment usually involves intravenous antibiotics, such as penicillin or ceftriaxone, and supportive care. Vaccination against meningococcal disease is a critical preventive measure, especially in high-risk populations.
Detailed clinical notes on symptoms, laboratory findings, and treatment plans.
Patients presenting with fever, headache, and neck stiffness.
Ensure that all relevant laboratory results are documented to support the diagnosis.
Comprehensive neurological assessments and imaging results.
Patients with neurological deficits or altered mental status due to meningitis.
Document any neurological examinations and findings to support the diagnosis.
Used to obtain cerebrospinal fluid for analysis in suspected meningitis cases.
Document indication for the procedure and findings from CSF analysis.
Ensure that the procedure is linked to the diagnosis of meningitis.
Use A39.4 when the serogroup of Neisseria meningitidis is not documented or known. If the serogroup is identified, use the corresponding specific code.
